Loading...
Grifols, S.A.
GRFS•NASDAQ
Healthcare
Drug Manufacturers - General
$10.10
$0.16(1.61%)
Grifols, S.A. (GRFS) Financial Performance & Income Statement Overview
Review Grifols, S.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
9.41%
↑ 9.41%
Operating Income Growth
61.54%
↑ 61.54%
Net Income Growth
164.55%
↑ 164.55%
Operating Cash Flow Growth
333.15%
↑ 333.15%
Operating Margin
15.83%
↑ 15.83%
Gross Margin
38.12%
↑ 38.12%
Net Profit Margin
2.60%
↑ 2.60%
ROE
3.38%
↑ 3.38%
ROIC
6.05%
↑ 6.05%
Grifols, S.A. (GRFS) Income Statement & Financial Overview
Review Grifols, S.A.'s (GRFS) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.98B | $1.79B | $1.82B | $1.63B |
| Cost of Revenue | $1.12B | $1.07B | $1.20B | $977.30M |
| Gross Profit | $851.76M | $726.75M | $620.78M | $648.41M |
| Gross Profit Ratio | $0.43 | $0.41 | $0.34 | $0.40 |
| R&D Expenses | $115.001M | $87.88M | $90.69M | $90.46M |
| SG&A Expenses | $230.008M | $319.43M | $299.69M | $316.14M |
| Operating Expenses | $432.99M | $409.72M | $368.36M | $444.61M |
| Total Costs & Expenses | $1.56B | $1.48B | $1.57B | $1.42B |
| Interest Income | $144.83M | $0.00 | $14.05M | $0.00 |
| Interest Expense | $295.75M | $197.61M | $221.40M | $0.00 |
| Depreciation & Amortization | -$26.25M | $108.36M | $101.02M | $105.62M |
| EBITDA | $481.91M | $425.40M | $353.43M | $347.53M |
| EBITDA Ratio | $0.24 | $0.24 | $0.19 | $0.21 |
| Operating Income | $418.77M | $317.03M | $252.41M | $203.80M |
| Operating Income Ratio | $0.21 | $0.18 | $0.14 | $0.13 |
| Other Income/Expenses (Net) | -$161.17M | -$197.61M | -$232.49M | -$156.75M |
| Income Before Tax | $257.60M | $119.42M | $19.92M | $47.06M |
| Income Before Tax Ratio | $0.13 | $0.07 | $0.01 | $0.03 |
| Income Tax Expense | $126.76M | $37.44M | $42.21M | $24.78M |
| Net Income | $68.97M | $51.69M | $14.84M | $21.42M |
| Net Income Ratio | $0.03 | $0.03 | $0.008 | $0.01 |
| EPS | $0.13 | $0.08 | $0.02 | $0.03 |
| Diluted EPS | $0.13 | $0.08 | $0.02 | $0.03 |
| Weighted Avg Shares Outstanding | $682.26M | $679.63M | $742.05M | $710.57M |
| Weighted Avg Shares Outstanding (Diluted) | $680.41M | $679.63M | $742.05M | $710.57M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan